Aortic aneurysms — dangerous bulges in the body’s main artery, the aorta — are becoming increasingly common as more people ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

It often starts with sudden, sharp chest pain that feels unlike anything you have experienced before. It might spread to your ...

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

Aortitis is rare, but it can lead to serious complications like heart failure and aortic aneurysms. Many of these symptoms can be signs of other life-threatening conditions. See a healthcare ...

Differential aortic aneurysm formation provoked by chemogenetic oxidative stress. Journal of Clinical Investigation , 2025; 135 (9) DOI: 10.1172/JCI188743 Cite This Page : ...

Even if you don’t have symptoms, your doctor may be able to detect aortic regurgitation by listening to your heart with a stethoscope. If your doctor hears a whooshing sound in between beats ...